{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:41:44Z","timestamp":1767148904338,"version":"build-2238731810"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":63,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurology Perspectives"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neurop.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T16:03:22Z","timestamp":1615133002000},"page":"104-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["S\u00edndrome de Guillain-Barr\u00e9 asociado a COVID-19: diagn\u00f3stico, tratamiento y rehabilitaci\u00f3n"],"prefix":"10.1016","volume":"1","author":[{"given":"R.","family":"Vallejo Serna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Cantor Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Arce G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurop.2021.03.003_bib0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.neurop.2021.03.003_bib0060","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1212\/NXI.0000000000000781","article-title":"Guillain-Barr\u00e9 syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing","volume":"7","author":"Dalakas","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.neurop.2021.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/acschemneuro.0c00181","article-title":"Updates on what ACS reported: emerging evidences of COVID-19 with nervous system involvement","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci."},{"key":"10.1016\/j.neurop.2021.03.003_bib0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.nrl.2020.07.004","article-title":"Relaci\u00f3n entre COVID-19 y s\u00edndrome de Guillain-Barr\u00e9 en adultos. Revisi\u00f3n sistem\u00e1tica","volume":"35","author":"Trujillo Gittermann","year":"2020","journal-title":"Neurolog\u00eda."},{"key":"10.1016\/j.neurop.2021.03.003_bib0075","unstructured":"Mackenzie N. Lopez-coronel E. A concomitant Guillain-Barre Syndrome with COVID-19: a first case-report in Colombia. 1 9. 10.21203\/rs.3.rs-61279\/v1"},{"key":"10.1016\/j.neurop.2021.03.003_bib0080","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barr\u00e9 syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.neurop.2021.03.003_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: A systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.neurop.2021.03.003_bib0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.neurop.2021.03.003_bib0095","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.neurop.2021.03.003_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nrl.2020.10.002","article-title":"Relation between COVID-19 and Guillain-Barre syndrome in adults. Systematic review","volume":"36","author":"Araya-Quintanilla","year":"2021","journal-title":"Neurolog\u00eda"}],"updated-by":[{"DOI":"10.1016\/j.neurop.2024.100165","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000}}],"container-title":["Neurology Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667049621000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667049621000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:21:42Z","timestamp":1763022102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667049621000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2667049621000065"],"URL":"https:\/\/doi.org\/10.1016\/j.neurop.2021.03.003","relation":{},"ISSN":["2667-0496"],"issn-type":[{"value":"2667-0496","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome de Guillain-Barr\u00e9 asociado a COVID-19: diagn\u00f3stico, tratamiento y rehabilitaci\u00f3n","name":"articletitle","label":"Article Title"},{"value":"Neurology Perspectives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurop.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}